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Abstract
Background: There is a growing interest in nonpharmacological approaches for essential tremor (ET), including tremor cancelation devices. However, the true 
efficacy of  such devices in ET remains unclear.
Methods: A systematic literature review was conducted using standardized criteria regarding efficacy and comfortability. Devices focused on design or  experimental 
testing in which tremor was simulated in a robot were excluded.
Results: Out of  324 articles initially identified, 12 articles were included. Orthoses using biomechanical loading and neuromodulation with electrical stimulation, 
and external tremor cancelation devices, were the main interventions used to suppress tremor. All devices were designed to control tremor of  the upper limbs at 
different anatomical locations. Overall, an average tremor attenuation of  50–98% was reported (level of  evidence III). Interference with voluntary movements and 
portability was described as the main drawback.
Discussion: In conclusion, this review highlights the growing interest in emerging tremor control devices and the importance of  assessing comfort without 
affecting voluntary movements. However, the level of  evidence regarding the efficacy of  these tremor control devices remains low. An integrated multidisciplinary 
combination approach of  engineering, robotics, physiology, physiotherapy, and clinical assessment is needed to improve the quality of  non-pharmacological 
 interventions for ET.
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Introduction
Tremor is defined as a rhythmic and involuntary movement of  any 
body part. It is the most common movement disorder that presents in a 
variety of  conditions, including essential tremor (ET), Parkinson’s disease 
(PD), dystonia, and cerebellar ataxia.1 Tremor is the pathognomonic 
 clinical sign in ET, with an estimated prevalence of  approximately 4% 
of  the population over 65 years of  age and an incidence rate of  616 
per 100,000 annually.1–4 ET classically involves the upper limbs and is 
generally triggered by arm movement and sustained antigravity postures, 
thus affecting common daily activities such as writing, using a glass for 
drinking, or handling cutlery.5 ET is a slowly progressive condition that 
can also involve the head, voice, and lower limbs.6 More than 65% of  the 
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population with upper limb tremor are seriously conditioned when 
 performing their activities of  daily living, leading in some cases to social 
exclusion.2 Furthermore, 34% of  the patients with ET present at least 
mild depression associated with a reduced performance in activities of  
daily living.5,7 Given that tremor-related disability can be significant, 
several therapies have been proposed. Initial treatment recommenda-
tion includes propranolol, primidone, and topiramate.8,9 However, the 
symptomatic benefit of  these drugs tends to decline over time, likely 
attributable to disease progression or development of  drug tolerance. 
Second-line agents include gabapentin, nimodipine, and others.8,9 
Patients not responding to pharmacological treatment may undergo 
surgical procedures such as deep brain stimulation, magnetic reso-
nance-guided focused ultrasound thalamotomy, or other ablative tech-
niques like gamma-knife radiosurgery.10
Alternative therapies are then needed for individuals presenting ET 
who respond poorly to medication, and for those in which surgery is not 
possible. Therefore, there is a growing interest in nonpharmacological 
therapies and functional rehabilitation for ET.11 Emerging nonpharma-
cological therapies for ET include (1) exoskeletons, which are wearable 
mechatronic systems, in which the physical interface provides a direct 
transfer of  mechanical power and some exchange of  information12,13; 
(2) orthoses, defined as a medical device that acts in parallel to a seg-
ment of  the body, in order to compensate some dysfunction14,15; and 
(3) handheld external devices such as spoons.16 However, to date, there 
is still little evidence on the effectiveness of  these devices in tremor sup-
pression. The objective of  this paper is to review the main advantages 
and disadvantages of  these emerging therapies from the neurologist’s 
perspective. A detailed biomechanical description of  the mechanism of  
action of  the devices is beyond the scope of  this review.
Methods
Search strategy and eligibility criteria
A literature search was performed using PubMed/MEDLINE, 
Scopus, Physiotherapy Evidence Database (PDRro), and Psychological 
Database for Brain Impairment Treatment Efficacy (PsycBITE). The 
search terms used were “essential tremor,” “devices,” “neuroprosthe-
sis,” “orthosis,” and “robot.” Eligible papers included studies on non-
pharmacological therapies for ET in either English or Spanish, 
published between January 1, 2000, and September 1, 2019. Articles 
on pharmacological or surgical treatments for ET devices focused on 
design or experimental testing, in which the human motion (both 
tremor and voluntary movement) was simulated in a robot, and studies 
including only non-ET tremor patients were excluded. The following 
outcomes measures were considered in this review: (1) benefit in terms of  
tremor reduction. On the one hand, clinical benefit was evaluated by 
different methodologies, including rating scales like the seven-point 
scale Clinical Global Impression Scale (CGI-S) and tremor rating 
scales (TRS) including the Fahn–Tolosa–Marin TRS17 and the Essential 
Tremor Rating Assessment Scale (TETRAS).18 On the other hand, 
benefit, from a biomechanical point of  view, was evaluated by using: 
(1) the tremor power, measured by power spectral density or PSD, 
(2) the root mean square (RMS) of  the tremor acceleration amplitude, 
(3) the average tremor acceleration (AA), and (4) the deflection ampli-
tude (AD)19; (2) Comfortability, which was mainly determined by the 
weight of  the device.
The level of  evidence for therapeutic studies was based on the recom-
mendations developed by the Centre for Evidence Based Medicine, 
taken into account the quality of  the data (levels from 1, highest quality 
[systematic review of  randomized clinical trials], 2 [cohort studies], 3 
[case-control studies], 4 [case series], to 5, lowest quality (expert opin-
ions, physiology bench research, or first principles]).20
Results
Following eligibility criteria, by consensus of  the authors, 12 articles 
were selected and reviewed (Figure 1 and Table 1). Devices were classi-
fied as orthoses using neuromodulation with electrical stimulation of  
pairs of  antagonist muscles opposing tremor oscillations,14,21–26 biome-
chanical loading with suppressive technologies like viscous and mag-
netic fluids, magnetic particle brakes, pneumatic actuators and motors, 
exoskeleton robots with tremor suppression control,27–32 and external 
tremor cancelation devices.16 All devices were primarily designed to 
control tremor of  the upper limbs. Five studies analyzed the devices that 
controlled the entire upper limb (including elbow/forearm and wrist), 
seven studies tested efficacy in one single joint, four studies addressed 
just the elbow, and three studies the wrist (Table 1). In one study, an 
external tremor control device (a spoon) was tested.16 Below, a brief  
description of  each device functionality is provided.
Manto et al.27 conducted a study in 12 subjects with tremor, in which 
they intended to develop the prototype of  a wearable active device, by 
characterizing the contribution of  each joint to the observed tremor of  
the upper limb, and analyzing the loads/forces needed to counteract the 
oscillations. In this article, parameters and constraints for constructing 
workable and usable active orthoses were presented, although no spe-
cific data in terms of  efficacy or side effects were reported.
Loureiro et al.28 developed an orthosis that can dynamically suppress 
pathological tremor by applying controlled viscous damping to the 
affected limb. This orthosis has an actuator based on magnetorheologi-
cal fluids that deliver the so-called damping action, meaning the dissipa-
tion of  the energy stored in an oscillatory movement, which reduces the 
occurrence and the amplitude of  tremor. Kinematic sensors analyze the 
mechanical characteristics of  tremor and discriminate between desired 
and undesired components of  motion. Biomechanical data from 33 
patients with tremor allowed for the implementation of  a prototype that 
was applied to one ET patient. This device, in which the damping coef-
ficient was 4 N·s/mm, significantly reduced tremor at the wrist and 
showed no side effects.
Rocon et al.12 tested in six subjects a robotic exoskeleton called wearable 
orthosis for tremor assessment and suppression (WOTAS). The device was 
based on two mechanisms: (1) tremor reduction through impedance con-
trol (defined by the relation between force and position), by modifying the 
stiffness, damping, and mass properties of  the upper limb; and (2) notch 
filtering, a system that attenuates only those frequencies coinciding with 
tremor. The exoskeleton has gyro sensors in each joint that provide input 
signals for control. The efficacy of  the device was assessed in 10 patients 
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with tremor disorders, by using both a passive control mode, analyzing the 
change in the biomechanical properties of  the upper limb (viscosity and 
inertia); and in an active control mode, by applying opposite forces to the 
tremor movement. A better tremor control was obtained with the active 
control mode (81.2% mean power reduction) compared to the passive 
suppression mode (70% mean power reduction). In a second study, as per-
formed in six subjects with ET,13 the authors observed a reduction of  
tremor up to 98%. However, users considered the exoskeleton a bulky and 
heavy apparatus that hindered adequate social life.
Gallego et al.14,24,25 tested the TREMOR neuro-robot, a type of  active 
wearable outfit, which incorporated an array of  electrodes sewn to the 
garment, both for electrical stimulation and recording. It included a 
brain–neural computer interface that monitored the whole neuromuscu-
loskeletal system. This device detects both voluntary movements and 
tremor, and is able to electrically stimulate pairs of  antagonist muscles 
exactly opposing tremor oscillations. Preliminary results indicated that 
efficacy varied considerably between patients with different types of  
tremor. In a PD patient, modiﬁcation of  joint impedance was effective in 
the suppression of  tremor (reaching 60% of  the peak-to-peak value, in 
tremor amplitude and frequency of  the PSD). In another ET patient, the 
average tremor reduction was 16.77 ± 8.33% of  the PSD. They also 
showed that tremor tended to migrate to proximal joints when suppressed 
more distally, thus supporting the need of  independent joint controllers.
Seki et al.21,22 conducted a study aimed to develop a filter, which used 
a neural network learning algorithm that reduces tremor-related 
 electromyographic noise, to better characterize tremor oscillations. 
They developed a prototype with a surface myoelectric sensor that col-
lected input signals, a signal processor that subtracted the voluntary 
movement, and a tremor recognition system that provided an output 
signal. The actuator was a harmonic drive system that suppressed 
Table 1. Main Results of  Search for Tremor Suppression Devices






Manto et al.27 ET (6) Orthosis biomechanical loading Elbow and wrist 0.850 III
Loureiro et al.28 Tremor (33)* Orthosis biomechanical loading Forearm, wrist <0.200 III
Rocon et al.11,12 ET (6), others (4) (PD, 
Multiple sclerosis, post-
anoxic tremor)
Exoskeleton biomechanical loading and 
notch filtering
Elbow and wrist 0.850 III
Gallego et al.13 Tremor (17) including PD, 
ET, cerebellar disorders
Soft-wearable robot (sleeve) 
biomechanical loading + functional 
electrical stimulation
Elbow and wrist ? III
Seki et al.21,22 ET (1) Myoelectric-controlled exoskeletal robot Elbow ? III
Popovic´ et al.26 PD (4)ET (3) Orthosis biomechanical loading
Functional electric stimulation
Wrist ? III
Ando et al.23 ET (1) Myoelectric-controlled exoskeletal robot Elbow 0.330 III
Gallego et al.24 ET (4)PD (2) Orthosis (textile) Functional electrical 
stimulation
Elbow and wrist ? III
Belda et al.30 ET (12) Orthosisbiomechanical loading Wrist ? III
Pathak et al.16 ET (15) Spoon External (hand) 0.100 III
Gallego et al.25 ET (1) Orthosis functional electrical stimulation Elbow ? III
Hermstadt et al. 31,32 ET (9) Orthosis biomechanical loading Elbow 1.7 III
Abbreviations: ET, Essential Tremor; PD, Parkinson’s Disease.
*Tremor was not clinically classified.
Arcles screened using various keywords 
and combinaons
N = 324
Abstracts and/or full-text arcles 
assessed for eligibility





Figure 1. PRISMA Flow Diagram for Identification of  Relevant 
Studies. Reasons for exclusion: *non-tremor control device studies; **abstracts, 
non-matched inclusion criteria studies, language (non-English or Spanish).
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the tremor. The results demonstrated that the proposed filter optimized 
motion recognition, especially on flexed postures. Using a similar proto-
type, Ando et al.23 developed an algorithm able to accurately recognize 
voluntary movements of  the elbow joint in patients with ET (89.5% 
average recognition rate). In one ET patient, a 50–80% reduction of  
action tremor while eating was observed, without significant side effects.
Popovic et al.26 developed a programmable multichannel stimulator 
that supported asynchronous activation of  several electrodes, and used 
inertial sensors attached to several joints. The software provided adap-
tive sensor-driven control for the out-of-phase stimulation. This system 
was used in seven patients (PD and ET) to improve wrist joint tremor. In 
all but one patient, the adaptive out-of-phase stimulation resulted in a 
signiﬁcant decrease in the amplitude of  tremor (67 ± 13%).
Belda et al.30 conducted a study over 12 ET patients using an orthosis 
prototype, with a rotary damper mechanism, which combined dry fric-
tion and viscous damping. Efficacy was evaluated with the TRS, spirals, 
and actions tasks. They observed a 33% reduction in tremor severity 
with no side effects.
Pathak et al.16 analyzed a handheld device that carried an active 
tremor cancelation device aimed to improve the use of  a regular spoon. 
Three specific tasks were tested in 15 ET subjects with this device turned 
“on” and “off.” Tremor severity was evaluated with the TRS, subjective 
improvement with the CGI-S, and tremor amplitude with device-em-
bedded accelerometers. TRS scores for all three tasks significantly 
improved when the device was on versus off  (holding, p = 0.01; eating, 
p = 0.001; and transferring, p = 0.001). CGI-S improved when eating 
and transferring but not for the holding task, and accelerometer mea-
surements demonstrated a 71–76% reduction in tremor when the device 
was on. However, this tremor cancelation system could not be used in 
two subjects with severe tremor, who had their DBS turned off, suggest-
ing that this device is most suitable for mild-moderate cases. Side effects 
were not observed.
Hernstadt et al.31,32 conducted a study to evaluate the feasibility of  a 
voluntary-driven, speed-controlled tremor suppression robotic orthosis 
for elbow tremor. They developed a prototype using a brushless rotatory 
electrical motor, connected to a commercial spur gearbox in combina-
tion with a custom gear reduction, embedded with a torque sensor and 
an encoder. Nine participants (ET and PD) performed computerized 
pursuit tracking tasks following a sinusoid and a random target, both 
with and without the tremor suppression orthosis. Efficacy was deter-
mined by the relative power change calculated with the PSD. Tremor 
severity was assessed with the performance section of  TETRAS. The 
suppressive orthosis resulted in a 94% mean power reduction of  tremor 
(p < 0.001). No significant impact on voluntary movements was 
observed. Nevertheless, the size and weight of  the device were consid-
ered a troublesome issue for the participants. They did not observe, 
however, migration of  tremor to nearby joints.
Discussion
This literature review shows that the level of  evidence regarding the 
efficacy of  the several types of  tremor suppression devices remains low. 
Most of  them are prototypes, tested in small and heterogeneous groups 
of  patients harboring different tremor disorders, providing little infor-
mation on comfort and impact of  its use on daily life activities and qual-
ity of  life. To develop and validate efficient tremor suppression devices, 
we need a better understanding of  (1) the anatomical features of  tremor, 
(2) how tremor originates, (3) what muscles are involved, and (4) how 
does it propagate to the hand, where it results most disabling.
The best anatomical location to place a tremor controller device of  
the upper limb still remains controversial. Likewise, it is not fully 
established what type of  movement control, and muscle stimulation 
in each joint, needs to be addressed for tremor improvement33: 
(1) elbow: ﬂexion/extension, (2) forearm: pronation/supination, 
(3) wrist:  ﬂexion/extension, or (4) wrist: abduction/adduction. 
Previous studies15 indicate that the first three pairs of  motions do have 
a significant impact on disability. Moreover, studies focused on the 
elbow joint31 have shown that elbow motion is the key to successfully 
perform most activities of  daily living.33
In terms of  daily living activities and quality of  life impairment, there 
is also still controversy whether disability of  ET patients is more associ-
ated with the frequency of  tremor,34 or with its amplitude,35,36 Of  note, 
another unsolved issue is tremor migration. Some authors have observed 
that tremor tends to migrate toward proximal joints when it is sup-
pressed more distally; for example, if  tremor is suppressed at the wrist 
level, it may appear or increase at the elbow or shoulder. This phenom-
enon has been reported in both PD and ET patients,25,37,38 although a 
specific physiologic explanation still lacks.
To develop tremor cancelation device prototypes, a few basic charac-
teristics have been suggested.19,25,32 The design of  the tremor suppres-
sion part of  an upper limb orthosis, the actuator, needs to include a 
sensing mechanism able to provide position, velocity, and acceleration 
information to the control and feedback system with minimum delay. 
These sensors need to extract information following a hierarchical inte-
gration scheme: first, to detect user’s intention to perform a certain vol-
untary movement; second, to evaluate tremor characteristics with an 
estimation of  its amplitude, frequency, and phase; and third, to deter-
mine how tremor affects each joint and which muscles contribute to 
joint tremor.14,23 The actuator, however, should ideally be light, small, 
easily attachable to the orthosis, noiseless; should respond fast; and con-
sume battery as little as possible. On the other hand, it is also very 
important to acknowledge patient’s comfort regarding the external 
appearance of  the device such as size and weight. Thus, indicators of  
voluntary movement restriction, like the degree of  freedom (DOF) coef-
ficient, and the weight per DOF, have been developed as recommended 
measurement tools of  usability/convenience.19
To effectively compare tremor suppression devices, some method-
ological aspects need to be considered. First, elaboration of  a standard 
common protocol, describing the tasks to be performed, is needed for 
adequate comparison. Second, tremor suppression efficacy needs objec-
tive assessments of  tremor with specific validated biomechanical out-
comes. Third, clinicians and engineers should use validated clinical 
rating scales/objective measurements for ET, reflecting tremor severity, 
impact on daily living activities, and quality of  life. Fourth, researchers 
should also evaluate combined outcome measures, like cost-effectiveness 
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variables,39 and the so-called minimum significant difference,40 defined 
as the smallest clinically significant change of  a specific variable, that the 
patient deems important.
Finally, validation of  tremor cancelation devices should adopt the 
same scientific methodology used for clinical trials in order to provide an 
adequate level of  evidence and extrapolation of  data. Well-designed lon-
gitudinal studies with a priori sample size calculation, adequate random-
ization and appropriate ethical compliance are therefore needed. In this 
regard, given that adequate blinding within trials can be challenging, the 
use of  objective tremor motion measurements used in these devices may 
overcome this difficulty.
This review has some limitations. It is widely recognized that Japanesse 
researchers are considered pioneers in robotics; however, translation into 
English or Spanish of  some papers written in Japanesse was not available 
for analysis. Additionally, we did not include some tremor cancelation 
devices, which were directly advertised at different websites, which did 
not provide any scientific literature that could be reviewed.
In conclusion, this review highlights the growing interest in emerging 
tremor control devices and the importance of  assessing comfort without 
affecting voluntary movements. However, the level of  evidence regard-
ing the efficacy of  these tremor control devices remains low. An inte-
grated multidisciplinary combination approach of  engineering, robotics, 
physiology, physiotherapy, and clinical assessment is needed to improve 
the quality of  nonpharmacological interventions for ET.
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